Skip to content
Pharmaceuticals
ONP-002
Technology & Pipeline
Pipeline
Science & Technology
News & Media
News & Media
Publications
Investors
Why Invest
About
Overview
Management Team
Board of Directors
Scientific Advisors
Contact Us
Navigation Menu
Navigation Menu
Pharmaceuticals
ONP-002
Technology & Pipeline
Pipeline
Science & Technology
News & Media
News & Media
Publications
Investors
Why Invest
About
Overview
Management Team
Board of Directors
Scientific Advisors
Contact Us
Contact Us
Investor Relations
📧
ir@oragenics.com
📞 1-813-286-7900
🏛 NYSE American:
OGEN
Access Investor Portal
Media Relations
📧
media@oragenics.com
📞 1-813-286-7900
General Inquiries
Please enable JavaScript in your browser to complete this form.
Please enable JavaScript in your browser to complete this form.
Name
*
First
Last
Email
*
Inquiry Type
*
Investor Inquiry
Media Inquiry
Clinical
Partnership
General
Name Message Email
Message
Send Message
Stock Information
Exchange
NYSE American
Ticker Symbol
OGEN
SEC Filings
View on EDGAR
View Investor Presentation
Read Latest News